Exact Mass: 486.2199922
Exact Mass Matches: 486.2199922
Found 500 metabolites which its exact mass value is equals to given mass value 486.2199922
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Austalide I
Austalide I is a mycotoxin from the food storage mould (Aspergillus ustus Mycotoxin from the food storage mould (Aspergillus ustus).
15-Acetoxyscirpene-3,4-diol 4-O-a-D-glucopyranoside
15-Acetoxyscirpene-3,4-diol 4-O-a-D-glucopyranoside is from Fusarium sulphureu From Fusarium sulphureum
Glucosylgalactosyl hydroxylysine
Glucosylgalactosyl hydroxylysine is a Glycoside of hydroxylysine. Hydroxylation of lysine is an important post-translational modification of collagen, (PMID 10928217) a reaction catalyzed by the enzyme Lysyl hydroxylase (EC 1.14.11.4) forming hydroxylysine in collagens and other proteins with collagen-like amino acid sequences, by the hydroxylation of lysine residues in X-lys-gly sequences. The hydroxylysine residues formed in the lysyl hydroxylase reaction have 2 important functions: first, their hydroxy groups serve as sites of attachment for carbohydrate units, either the monosaccharide galactose or the disaccharide glucosylgalactose; and second, they are essential for the stability of the intermolecular collagen crosslinks. (OMIM 153454). Hydroxylysine-deficient skin collagen is manifested in Ehlers-Danlos syndrome, type VIA, A heritable disorder of connective tissue (PMID 5016372). Glucosylgalactosyl hydroxylysine is a Glycoside of hydroxylysine. Hydroxylation of lysine is an important post-translational modification of collagen, (PMID 10928217) a reaction catalyzed by the enzyme Lysyl hydroxylase (EC 1.14.11.4) forming hydroxylysine in collagens and other proteins with collagen-like amino acid sequences, by the hydroxylation of lysine residues in X-lys-gly sequences.
2-O-alpha-D-Glucopyranosyl-O-beta-D-galactopyranosylhydroxylysine
Antibiotic LL-AB 664
C18H30N8O8 (486.21864999999997)
Apadenoson
4-[6-[(6-O-Acetyl-beta-D-glucopyranosyl)oxy]-3-methyl-2-oxohexyl]dihydro-3-methylene-5-(2-oxopropyl)-2(3H)-furanone
2-{O3-carbamoyl-2-[(N-formimidoyl-glycyl)-methyl-amino]-beta-D-2-deoxy-gulopyranosylamino}-7-hydroxy-5-methyl-1(3),3a,5,6,7,7a-hexahydro-imidazo[4,5-c]pyridin-4-one
C18H30N8O8 (486.21864999999997)
6-O-(4-methoxybenzoyl)crescentin IV 3-O-beta-D-glucopyranoside
1-(4-beta-D-glucopyranosyloxybenzyl) 4-ethyl (2R)-2-isobutylmalate
(2S)-5-hydroxy-2-(5-hydroxy-3,4-dimethoxyphenyl)-8-(4-hydroxy-4-methylpentyl)-8-methyl-2,3,7,8-tetrahydropyrano[3,2-g]chromen-4(6H)-one|Tomentin C
2-hydroxy-4-(2-hydroxy-4-methoxy-6-(2-oxoheptyl)benzoyloxy)-6-pentylbenzoic acid
(2S)-5-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-8-(4-hydroxy-4-methylpentyl)-8-methyl-2,3,7,8-tetrahydropyrano[3,2-g]chromen-4(6H)-one|Tomentin D
3-deoxo-1,2-dihydro-3-hydroxy-(2beta,3beta)-daphnetoxin
(+)-4-(3-methylbutanoyl)-2,6-di(3,4-dimethoxy)phenyl-3,7-dioxabicyclo[3.3.0]octane
2-methyl-1-[2,4,6-trihydroxy-3-[1-(4-hydroxy-6-methoxy-1,3-benzodioxol-5-yl)-2-methylpropyl]-5-(3-methyl-2-butenyl)phenyl]-1-propanone
C27H34O8_Methyl [(1S,3S,7R,8R,9R,12S,13S)-13-(3-furyl)-6,6,8,12-tetramethyl-17-methylene-5,15-dioxo-2,14-dioxatetracyclo[7.7.1.0~1,12~.0~3,8~]heptadec-7-yl](hydroxy)acetate
methyl (2R)-2-[(1S,3S,7R,8R,9R,12S,13R)-13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-5,15-dioxo-2,14-dioxatetracyclo[7.7.1.0¹,¹².0³,⁸]heptadecan-7-yl]-2-hydroxyacetate
(2R,2R,4aS,6S,7R,8aS)-6,7-diformyl-4-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydro-2H,3H-spiro[benzofuran-2,1-naphthalene]-6,7-diyl diacetate
Ala Ala Tyr Tyr
Ala Phe Ser Tyr
Ala Phe Tyr Ser
Ala His Pro Tyr
Ala His Tyr Pro
Ala Asn Pro Trp
Ala Asn Trp Pro
Ala Pro His Tyr
Ala Pro Asn Trp
Ala Pro Trp Asn
Ala Pro Tyr His
Ala Ser Phe Tyr
Ala Ser Tyr Phe
Ala Trp Asn Pro
Ala Trp Pro Asn
Ala Tyr Ala Tyr
Ala Tyr Phe Ser
Ala Tyr His Pro
Ala Tyr Pro His
Ala Tyr Ser Phe
Ala Tyr Tyr Ala
Asp Pro Gln Gln
C19H30N6O9 (486.20741699999996)
Asp Gln Pro Gln
C19H30N6O9 (486.20741699999996)
Asp Gln Gln Pro
C19H30N6O9 (486.20741699999996)
Glu Glu Ile Pro
Glu Glu Leu Pro
Glu Glu Pro Ile
Glu Glu Pro Leu
Glu His Thr Thr
C19H30N6O9 (486.20741699999996)
Glu Ile Glu Pro
Glu Ile Pro Glu
Glu Leu Glu Pro
Glu Leu Pro Glu
Glu Asn Pro Gln
C19H30N6O9 (486.20741699999996)
Glu Asn Gln Pro
C19H30N6O9 (486.20741699999996)
Glu Pro Glu Ile
Glu Pro Glu Leu
Glu Pro Ile Glu
Glu Pro Leu Glu
Glu Pro Asn Gln
C19H30N6O9 (486.20741699999996)
Glu Pro Gln Asn
C19H30N6O9 (486.20741699999996)
Glu Gln Asn Pro
C19H30N6O9 (486.20741699999996)
Glu Gln Pro Asn
C19H30N6O9 (486.20741699999996)
Glu Thr His Thr
C19H30N6O9 (486.20741699999996)
Glu Thr Thr His
C19H30N6O9 (486.20741699999996)
Phe Ala Ser Tyr
Phe Ala Tyr Ser
Phe Phe Ser Ser
Phe Gly Thr Tyr
Phe Gly Tyr Thr
Phe His Pro Ser
Phe His Ser Pro
Phe Pro His Ser
Phe Pro Ser His
Phe Ser Ala Tyr
Phe Ser Phe Ser
Phe Ser His Pro
Phe Ser Pro His
Phe Ser Ser Phe
Phe Ser Tyr Ala
Phe Thr Gly Tyr
Phe Thr Tyr Gly
Phe Tyr Ala Ser
Phe Tyr Gly Thr
Phe Tyr Ser Ala
Phe Tyr Thr Gly
Gly Phe Thr Tyr
Gly Phe Tyr Thr
Gly His His His
C20H26N10O5 (486.2087546000001)
Gly Pro Gln Trp
Gly Pro Trp Gln
Gly Gln Pro Trp
Gly Gln Trp Pro
Gly Thr Phe Tyr
Gly Thr Tyr Phe
Gly Trp Pro Gln
Gly Trp Gln Pro
Gly Tyr Phe Thr
Gly Tyr Thr Phe
His Ala Pro Tyr
His Ala Tyr Pro
His Glu Thr Thr
C19H30N6O9 (486.20741699999996)
His Phe Pro Ser
His Phe Ser Pro
His Gly His His
C20H26N10O5 (486.2087546000001)
His His Gly His
C20H26N10O5 (486.2087546000001)
His His His Gly
C20H26N10O5 (486.2087546000001)
His His Pro Pro
His Ile Met Ser
C20H34N6O6S (486.22604240000004)
His Ile Ser Met
C20H34N6O6S (486.22604240000004)
His Leu Met Ser
C20H34N6O6S (486.22604240000004)
His Leu Ser Met
C20H34N6O6S (486.22604240000004)
His Met Ile Ser
C20H34N6O6S (486.22604240000004)
His Met Leu Ser
C20H34N6O6S (486.22604240000004)
His Met Ser Ile
C20H34N6O6S (486.22604240000004)
His Met Ser Leu
C20H34N6O6S (486.22604240000004)
His Met Thr Val
C20H34N6O6S (486.22604240000004)
His Met Val Thr
C20H34N6O6S (486.22604240000004)
His Pro Ala Tyr
His Pro Phe Ser
His Pro His Pro
His Pro Ser Phe
His Pro Tyr Ala
His Ser Phe Pro
His Ser Ile Met
C20H34N6O6S (486.22604240000004)
His Ser Leu Met
C20H34N6O6S (486.22604240000004)
His Ser Met Ile
C20H34N6O6S (486.22604240000004)
His Ser Met Leu
C20H34N6O6S (486.22604240000004)
His Ser Pro Phe
His Thr Glu Thr
C19H30N6O9 (486.20741699999996)
His Thr Met Val
C20H34N6O6S (486.22604240000004)
His Thr Thr Glu
C19H30N6O9 (486.20741699999996)
His Thr Val Met
C20H34N6O6S (486.22604240000004)
His Val Met Thr
C20H34N6O6S (486.22604240000004)
His Val Thr Met
C20H34N6O6S (486.22604240000004)
His Tyr Ala Pro
His Tyr Pro Ala
Ile Glu Glu Pro
Ile Glu Pro Glu
Ile His Met Ser
C20H34N6O6S (486.22604240000004)
Ile His Ser Met
C20H34N6O6S (486.22604240000004)
Ile Met His Ser
C20H34N6O6S (486.22604240000004)
Ile Met Ser His
C20H34N6O6S (486.22604240000004)
Ile Pro Glu Glu
Ile Ser His Met
C20H34N6O6S (486.22604240000004)
Ile Ser Met His
C20H34N6O6S (486.22604240000004)
Leu Glu Glu Pro
Leu Glu Pro Glu
Leu His Met Ser
C20H34N6O6S (486.22604240000004)
Leu His Ser Met
C20H34N6O6S (486.22604240000004)
Leu Met His Ser
C20H34N6O6S (486.22604240000004)
Leu Met Ser His
C20H34N6O6S (486.22604240000004)
Leu Pro Glu Glu
Leu Ser His Met
C20H34N6O6S (486.22604240000004)
Leu Ser Met His
C20H34N6O6S (486.22604240000004)
Met His Ile Ser
C20H34N6O6S (486.22604240000004)
Met His Leu Ser
C20H34N6O6S (486.22604240000004)
Met His Ser Ile
C20H34N6O6S (486.22604240000004)
Met His Ser Leu
C20H34N6O6S (486.22604240000004)
Met His Thr Val
C20H34N6O6S (486.22604240000004)
Met His Val Thr
C20H34N6O6S (486.22604240000004)
Met Ile His Ser
C20H34N6O6S (486.22604240000004)
Met Ile Ser His
C20H34N6O6S (486.22604240000004)
Met Leu His Ser
C20H34N6O6S (486.22604240000004)
Met Leu Ser His
C20H34N6O6S (486.22604240000004)
Met Ser His Ile
C20H34N6O6S (486.22604240000004)
Met Ser His Leu
C20H34N6O6S (486.22604240000004)
Met Ser Ile His
C20H34N6O6S (486.22604240000004)
Met Ser Leu His
C20H34N6O6S (486.22604240000004)
Met Thr His Val
C20H34N6O6S (486.22604240000004)
Met Thr Val His
C20H34N6O6S (486.22604240000004)
Met Val His Thr
C20H34N6O6S (486.22604240000004)
Met Val Thr His
C20H34N6O6S (486.22604240000004)
Asn Ala Pro Trp
Asn Ala Trp Pro
Asn Glu Pro Gln
C19H30N6O9 (486.20741699999996)
Asn Glu Gln Pro
C19H30N6O9 (486.20741699999996)
Asn Pro Ala Trp
Asn Pro Glu Gln
C19H30N6O9 (486.20741699999996)
Asn Pro Gln Glu
C19H30N6O9 (486.20741699999996)
Asn Pro Trp Ala
Asn Gln Glu Pro
C19H30N6O9 (486.20741699999996)
Asn Gln Pro Glu
C19H30N6O9 (486.20741699999996)
Asn Trp Ala Pro
Asn Trp Pro Ala
Pro Ala His Tyr
Pro Ala Asn Trp
Pro Ala Trp Asn
Pro Ala Tyr His
Pro Asp Gln Gln
C19H30N6O9 (486.20741699999996)
Pro Glu Glu Ile
Pro Glu Glu Leu
Pro Glu Ile Glu
Pro Glu Leu Glu
Pro Glu Asn Gln
C19H30N6O9 (486.20741699999996)
Pro Glu Gln Asn
C19H30N6O9 (486.20741699999996)
Pro Phe His Ser
Pro Phe Ser His
Pro Gly Gln Trp
Pro Gly Trp Gln
Pro His Ala Tyr
Pro His Phe Ser
Pro His Ser Phe
Pro His Tyr Ala
Pro Ile Glu Glu
Pro Leu Glu Glu
Pro Asn Ala Trp
Pro Asn Glu Gln
C19H30N6O9 (486.20741699999996)
Pro Asn Gln Glu
C19H30N6O9 (486.20741699999996)
Pro Asn Trp Ala
Pro Gln Asp Gln
C19H30N6O9 (486.20741699999996)
Pro Gln Glu Asn
C19H30N6O9 (486.20741699999996)
Pro Gln Gly Trp
Pro Gln Asn Glu
C19H30N6O9 (486.20741699999996)
Pro Gln Gln Asp
C19H30N6O9 (486.20741699999996)
Pro Gln Trp Gly
Pro Ser Phe His
Pro Ser His Phe
Pro Trp Ala Asn
Pro Trp Gly Gln
Pro Trp Asn Ala
Pro Trp Gln Gly
Pro Tyr Ala His
Pro Tyr His Ala
Gln Asp Pro Gln
C19H30N6O9 (486.20741699999996)
Gln Asp Gln Pro
C19H30N6O9 (486.20741699999996)
Gln Glu Asn Pro
C19H30N6O9 (486.20741699999996)
Gln Glu Pro Asn
C19H30N6O9 (486.20741699999996)
Gln Gly Pro Trp
Gln Gly Trp Pro
Gln Asn Glu Pro
C19H30N6O9 (486.20741699999996)
Gln Asn Pro Glu
C19H30N6O9 (486.20741699999996)
Gln Pro Asp Gln
C19H30N6O9 (486.20741699999996)
Gln Pro Glu Asn
C19H30N6O9 (486.20741699999996)
Gln Pro Gly Trp
Gln Pro Asn Glu
C19H30N6O9 (486.20741699999996)
Gln Pro Gln Asp
C19H30N6O9 (486.20741699999996)
Gln Pro Trp Gly
Gln Gln Asp Pro
C19H30N6O9 (486.20741699999996)
Gln Gln Pro Asp
C19H30N6O9 (486.20741699999996)
Gln Trp Gly Pro
Gln Trp Pro Gly
Ser Ala Phe Tyr
Ser Ala Tyr Phe
Ser Phe Ala Tyr
Ser Phe Phe Ser
Ser Phe His Pro
Ser Phe Pro His
Ser Phe Ser Phe
Ser Phe Tyr Ala
Ser His Phe Pro
Ser His Ile Met
C20H34N6O6S (486.22604240000004)
Ser His Leu Met
C20H34N6O6S (486.22604240000004)
Ser His Met Ile
C20H34N6O6S (486.22604240000004)
Ser His Met Leu
C20H34N6O6S (486.22604240000004)
Ser His Pro Phe
Ser Ile His Met
C20H34N6O6S (486.22604240000004)
Ser Ile Met His
C20H34N6O6S (486.22604240000004)
Ser Leu His Met
C20H34N6O6S (486.22604240000004)
Ser Leu Met His
C20H34N6O6S (486.22604240000004)
Ser Met His Ile
C20H34N6O6S (486.22604240000004)
Ser Met His Leu
C20H34N6O6S (486.22604240000004)
Ser Met Ile His
C20H34N6O6S (486.22604240000004)
Ser Met Leu His
C20H34N6O6S (486.22604240000004)
Ser Pro Phe His
Ser Pro His Phe
Ser Ser Phe Phe
Ser Tyr Ala Phe
Ser Tyr Phe Ala
Thr Glu His Thr
C19H30N6O9 (486.20741699999996)
Thr Glu Thr His
C19H30N6O9 (486.20741699999996)
Thr Phe Gly Tyr
Thr Phe Tyr Gly
Thr Gly Phe Tyr
Thr Gly Tyr Phe
Thr His Glu Thr
C19H30N6O9 (486.20741699999996)
Thr His Met Val
C20H34N6O6S (486.22604240000004)
Thr His Thr Glu
C19H30N6O9 (486.20741699999996)
Thr His Val Met
C20H34N6O6S (486.22604240000004)
Thr Met His Val
C20H34N6O6S (486.22604240000004)
Thr Met Val His
C20H34N6O6S (486.22604240000004)
Thr Thr Glu His
C19H30N6O9 (486.20741699999996)
Thr Thr His Glu
C19H30N6O9 (486.20741699999996)
Thr Val His Met
C20H34N6O6S (486.22604240000004)
Thr Val Met His
C20H34N6O6S (486.22604240000004)
Thr Tyr Phe Gly
Thr Tyr Gly Phe
Val His Met Thr
C20H34N6O6S (486.22604240000004)
Val His Thr Met
C20H34N6O6S (486.22604240000004)
Val Met His Thr
C20H34N6O6S (486.22604240000004)
Val Met Thr His
C20H34N6O6S (486.22604240000004)
Val Thr His Met
C20H34N6O6S (486.22604240000004)
Val Thr Met His
C20H34N6O6S (486.22604240000004)
Trp Ala Asn Pro
Trp Ala Pro Asn
Trp Gly Pro Gln
Trp Gly Gln Pro
Trp Asn Ala Pro
Trp Asn Pro Ala
Trp Pro Ala Asn
Trp Pro Gly Gln
Trp Pro Asn Ala
Trp Pro Gln Gly
Trp Gln Gly Pro
Trp Gln Pro Gly
Tyr Ala Ala Tyr
Tyr Ala Phe Ser
Tyr Ala His Pro
Tyr Ala Pro His
Tyr Ala Ser Phe
Tyr Ala Tyr Ala
Tyr Phe Ala Ser
Tyr Phe Gly Thr
Tyr Phe Ser Ala
Tyr Phe Thr Gly
Tyr Gly Phe Thr
Tyr Gly Thr Phe
Tyr His Ala Pro
Tyr His Pro Ala
Tyr Pro Ala His
Tyr Pro His Ala
Tyr Ser Ala Phe
Tyr Ser Phe Ala
Tyr Thr Phe Gly
Tyr Thr Gly Phe
Tyr Tyr Ala Ala
Austalide I
15-Acetoxyscirpene-3,4-diol 4-O-a-D-glucopyranoside
N^a-Boc-N^w-(4-Methoxy-2,3,6-triMethylphenylsulfonyl)-D-arginine
C21H34N4O7S (486.21480940000004)
3,5-O-(1,1,3,3-TETRAISOPROPYL-1,3-DISILOXANEDIYL)URIDINE
N-(4-(phenyl-9H-carbazol-3-yl)phenyl)biphenyl-4-aMine
2-[5-chloro-2-(4-chlorophenyl)-1H-indol-3-yl]-N,N-dihexylacetamide
[5-[[2-(aminomethylideneamino)acetyl]-methylamino]-4-hydroxy-2-(hydroxymethyl)-6-[(7-hydroxy-5-methyl-4-oxo-3a,6,7,7a-tetrahydro-1H-imidazo[4,5-c]pyridin-2-yl)amino]oxan-3-yl] carbamate
C18H30N8O8 (486.21864999999997)
N-[3-[2-(dimethylamino)ethoxy]-4-methoxyphenyl]-4-[2-methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]benzamide
3-deamino-3-hydroxykanamycin X
A kanamycin that is kanamycin X in which the 3-amino group has been replaced by a hydroxy group.
N-(2,2-Dimethyl-5-morpholin-4-yl-1,4-dihydro-2H-3,7-dithia-6,9,11-triaza-benzo[c]fluoren-8-yl)-N,N-diet hyl-ethane-1,2-diamine
[(1S,2R,9R,10R,11S)-10-Hydroxy-1,5-dimethyl-11-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-2-yl]methyl acetate
(2S,3S,3aR,9bR)-7-(1-cyclohexenyl)-3-(hydroxymethyl)-1-(4-oxazolylmethyl)-6-oxo-N-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-7-(cyclohexen-1-yl)-3-(hydroxymethyl)-1-(1,3-oxazol-4-ylmethyl)-6-oxo-N-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(1R,9S,10S,11S)-10-(hydroxymethyl)-11-(morpholine-4-carbonyl)-5-phenyl-12-(pyridin-3-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
(1S,9R,10R,11R)-10-(hydroxymethyl)-11-(morpholine-4-carbonyl)-5-phenyl-12-(pyridin-3-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
(2S)-2-[(4R,5S)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl(5-pyrimidinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C25H34N4O4S (486.23006440000006)
2-[(3R,6aR,8R,10aR)-1-[(2,5-difluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
C27H32F2N2O4 (486.23300159999997)
2-[(3S,6aS,8R,10aS)-1-[(2,5-difluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
C27H32F2N2O4 (486.23300159999997)
2-[(3R,6aS,8S,10aS)-1-[(2,5-difluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
C27H32F2N2O4 (486.23300159999997)
(1R,9S,10S,11S)-5-(3-fluorophenyl)-10-(hydroxymethyl)-11-N-(2-methoxyethyl)-6-oxo-12-N-propan-2-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
(1S,9R,10R,11R)-5-(3-fluorophenyl)-10-(hydroxymethyl)-11-N-(2-methoxyethyl)-6-oxo-12-N-propan-2-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
(1R,9S,10S,11S)-12-N-(2,5-difluorophenyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-11-N-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
(1S,9R,10R,11R)-12-N-(2,5-difluorophenyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-11-N-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
4-Ethoxycarbonyl-3-[3-(ethylamino)-6-ethylimino-2,7-dimethylxanthen-9-yl]benzoic acid
methyl (2R)-2-[(1S,3S,7R,8R,12S,13S)-13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-5,15-dioxo-2,14-dioxatetracyclo[7.7.1.01,12.03,8]heptadecan-7-yl]-2-hydroxyacetate
5-[(alpha-D-glucopyranosyl-(1->2)-beta-D-galactopyranosyl)oxy]-L-lysine
An O-glycosyl amino acid that is L-lysine in which one of the methylene hydrogens at position 5 has been replaced by an (alpha-D-glucopyranosyl-(1->2)-beta-D-galactopyranosyl)oxy group.
TAN-452
TAN-452 is an orally active, selective peripherally acting δ-opioid receptor (DOR) antagonist with a Ki of 0.47?nM and a Kb of 0.21?nM. TAN-452 is an antagonist for μ-opioid receptor (MOR; Ki=36.56?nM and Kb=9.43?nM) and κ-opioid receptor (KOR; Ki=5.31?nM and Kb=7.18?nM). TAN-452, a derivative of Naltrindole, demonstrates low brain penetrability and attenuates morphine-induced side effects without affecting pain control[1].
methyl (2r)-2-[(1r,2s,5r,6r,13s,14r,16s)-6-(furan-3-yl)-14-hydroxy-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-10-en-16-yl]-2-hydroxyacetate
(9r,10r,11s)-19-hydroxy-3,4,5-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(19),2(7),3,5,12,14(18)-hexaen-11-yl 2-methylbutanoate
(1r,2r,3r,4s)-4-hydroxy-3-(hydroxymethyl)-4-methyl-2-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)cyclopentyl 4-methoxybenzoate
4-hydroxy-3-(hydroxymethyl)-4-methyl-2-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)cyclopentyl 4-methoxybenzoate
methyl (2e,3e,5e)-6-[3',3'-dimethyl-5'-(2-methylprop-1-en-1-yl)-3h-spiro[1,4-benzodioxine-2,2'-[1,4]dioxolan]-7-yl]-4-methoxy-2-(methoxymethylidene)-3-methylhexa-3,5-dienoate
(9s)-2,3,6-trihydroxy-4,5-dimethoxy-7-methyl-10-oxo-9h-anthracen-9-yl decanoate
(1r,5s,6r,14r,15s,17r,22s)-10,15-dihydroxy-6,14,18,18,22-pentamethyl-8,19-dioxo-7,13-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-3,9,11-trien-5-yl acetate
7a,9,11,11b-tetrahydroxy-3-(4-methoxyphenyl)-5a,8,8,11a-tetramethyl-6,7,9,10,11,12-hexahydro-2,5-dioxatetraphen-1-one
methyl 2-[(1s,3s,5r,7s,8r,10s,12s,13s)-13-(furan-3-yl)-5-hydroxy-6,6,8,12-tetramethyl-17-methylidene-9,15-dioxo-2,14-dioxatetracyclo[8.6.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate
10,15-dihydroxy-6,14,18,18,22-pentamethyl-8,19-dioxo-7,13-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-3,9,11-trien-5-yl acetate
[(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(4r)-4-methyl-6-[(2r,3r)-4-methylidene-5-oxo-2-(2-oxopropyl)oxolan-3-yl]-5-oxohexyl]oxy}oxan-2-yl]methyl acetate
(+)-4-(3-methylbutanoyl)-2,6-di(3,4-dimeth-oxy)phenyl-3,7-dioxabicyclo[3.3.0]octane
{"Ingredient_id": "HBIN009913","Ingredient_name": "(+)-4-(3-methylbutanoyl)-2,6-di(3,4-dimeth-oxy)phenyl-3,7-dioxabicyclo[3.3.0]octane","Alias": "NA","Ingredient_formula": "C27H34O8","Ingredient_Smile": "CC(C)CC(=O)OC1C2C(COC2C3=CC(=C(C=C3)OC)OC)C(O1)C4=CC(=C(C=C4)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14158","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}